Brandee Pappalardo

1.6k total citations
23 papers, 1.3k citations indexed

About

Brandee Pappalardo is a scholar working on Epidemiology, Genetics and Virology. According to data from OpenAlex, Brandee Pappalardo has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Genetics and 8 papers in Virology. Recurrent topics in Brandee Pappalardo's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (7 papers) and Bartonella species infections research (6 papers). Brandee Pappalardo is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (7 papers) and Bartonella species infections research (6 papers). Brandee Pappalardo collaborates with scholars based in United States, Canada and France. Brandee Pappalardo's co-authors include Edward B. Breitschwerdt, Michael P. Busch, David J. Wright, T. T. Brown, Sally Caglioti, Susan L. Stramer, Simone A. Glynn, Douglas M. Strong, Steven Kleinman and María T. Correa and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Brandee Pappalardo

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandee Pappalardo United States 16 553 543 405 403 308 23 1.3k
Jean Pierre Allain United Kingdom 17 483 0.9× 474 0.9× 445 1.1× 54 0.1× 236 0.8× 30 1.3k
Bruce A. Lenes United States 14 444 0.8× 309 0.6× 240 0.6× 50 0.1× 113 0.4× 19 1.7k
Sally Caglioti United States 16 826 1.5× 710 1.3× 169 0.4× 84 0.2× 552 1.8× 18 1.6k
Tandakha Ndiaye Dièye Senegal 20 240 0.4× 253 0.5× 198 0.5× 199 0.5× 47 0.2× 60 1.1k
Merlin H. Sayers United States 12 457 0.8× 243 0.4× 109 0.3× 113 0.3× 34 0.1× 17 1.0k
M.P. Busch United States 17 542 1.0× 371 0.7× 306 0.8× 23 0.1× 290 0.9× 19 1.0k
Meyers Jd United States 16 1.2k 2.1× 274 0.5× 86 0.2× 161 0.4× 45 0.1× 25 1.5k
Philip Kiely Australia 18 602 1.1× 347 0.6× 52 0.1× 23 0.1× 401 1.3× 46 972
Alec E. Wittek United States 18 997 1.8× 395 0.7× 247 0.6× 104 0.3× 68 0.2× 30 1.4k
Christoph Niederhauser Switzerland 15 314 0.6× 367 0.7× 105 0.3× 20 0.0× 349 1.1× 59 813

Countries citing papers authored by Brandee Pappalardo

Since Specialization
Citations

This map shows the geographic impact of Brandee Pappalardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandee Pappalardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandee Pappalardo more than expected).

Fields of papers citing papers by Brandee Pappalardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandee Pappalardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandee Pappalardo. The network helps show where Brandee Pappalardo may publish in the future.

Co-authorship network of co-authors of Brandee Pappalardo

This figure shows the co-authorship network connecting the top 25 collaborators of Brandee Pappalardo. A scholar is included among the top collaborators of Brandee Pappalardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandee Pappalardo. Brandee Pappalardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Louis, Édouard, Walter Reinisch, David A. Schwartz, et al.. (2018). Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies. Advances in Therapy. 35(4). 563–576. 17 indexed citations
2.
Dubinsky, Marla C., Raymond K. Cross, William J. Sandborn, et al.. (2018). Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(9). 1876–1882. 61 indexed citations
3.
Colombel, Jean‐Frédéric, William J. Sandborn, Walter Reinisch, et al.. (2017). Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Alimentary Pharmacology & Therapeutics. 47(2). 219–228. 32 indexed citations
4.
Travis, Simon, Brian G. Feagan, Laurent Peyrin‐Biroulet, et al.. (2017). Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA. Journal of Crohn s and Colitis. 11(11). 1317–1325. 36 indexed citations
6.
Ghosh, Subrata, William J. Sandborn, Jean‐Frédéric Colombel, et al.. (2016). Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 22(11). 2711–2723. 15 indexed citations
7.
Louis, Édouard, Robert Löfberg, Walter Reinisch, et al.. (2016). Mo1791 Adalimumab Treatment Reduces Extraintestinal Manifestations in Patients With Moderate to Severe Crohn's Disease: A Pooled Analysis. Gastroenterology. 150(4). S777–S777. 2 indexed citations
8.
Walters, Thomas D., William A. Faubion, Anne M. Griffiths, et al.. (2014). P-072: Growth improvement in adalimumab-treated paediatric patients with Crohn’s disease: data from IMAgINE 1. Journal of Crohn s and Colitis. 8. S420–S421.
9.
Page, Kimberly, Brandee Pappalardo, Leslie H. Tobler, et al.. (2007). Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates. Journal of Clinical Microbiology. 46(2). 499–506. 83 indexed citations
10.
Norris, Philip J., Brandee Pappalardo, Brian Custer, et al.. (2006). Elevations in IL-10, TNF- α , and IFN- γ from the Earliest Point of HIV Type 1 Infection. AIDS Research and Human Retroviruses. 22(8). 757–762. 95 indexed citations
11.
Hare, C. Bradley, Brandee Pappalardo, Michael P. Busch, et al.. (2006). Seroreversion in Subjects Receiving Antiretroviral Therapy during Acute/Early HIV Infection. Clinical Infectious Diseases. 42(5). 700–708. 72 indexed citations
12.
Busch, Michael P., Simone A. Glynn, Susan L. Stramer, et al.. (2005). A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 45(2). 254–264. 312 indexed citations
13.
Sabino, Éster Cerdeira, Thelma T. Gonçalez, Megan E. Laycock, et al.. (2005). Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first‐time blood donors in São Paulo, Brazil. Transfusion. 45(11). 1709–1714. 54 indexed citations
14.
Pappalardo, Brandee. (2003). Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. International Journal of Epidemiology. 32(5). 727–734. 67 indexed citations
15.
Pappalardo, Brandee, T. T. Brown, Mary B. Tompkins, & Edward B. Breitschwerdt. (2001). Immunopathology of Bartonella vinsonii (berkhoffii) in experimentally infected dogs. Veterinary Immunology and Immunopathology. 83(3-4). 125–147. 59 indexed citations
16.
Pappalardo, Brandee, et al.. (2000). Granulomatous Disease Associated with Bartonella Infection in 2 Dogs. Journal of Veterinary Internal Medicine. 14(1). 37–42. 51 indexed citations
17.
Pappalardo, Brandee, et al.. (2000). Cyclic CD8+ lymphopenia in dogs experimentally infected with Bartonella vinsonii subsp. berkhoffii. Veterinary Immunology and Immunopathology. 75(1-2). 43–57. 32 indexed citations
18.
Pappalardo, Brandee, et al.. (2000). Granulomatous Disease Associated with Bartonella Infection in 2 Dogs. Journal of Veterinary Internal Medicine. 14(1). 37–37. 75 indexed citations
19.
Baneth, Gad, et al.. (1998). A survey of tick-borne bacteria and protozoa in naturally exposed dogs from Israel. Veterinary Parasitology. 74(2-4). 133–142. 73 indexed citations
20.
Pappalardo, Brandee, et al.. (1997). Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs. American Journal of Veterinary Research. 58(5). 467–471. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026